Bristol-Myers Squibb (NY:BMY)

Got $500? This Top Dividend ETF Is a Great Buy After Its Recent Sell-Off. ↗

December 23, 2024

Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More ↗

Topics ETFs

December 22, 2024

JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.

Via Benzinga

Bristol Myers Squibb Stock Earns 83 RS Rating ↗

December 19, 2024

On Thursday, Bristol Myers Squibb stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83.

Via Investor's Business Daily

Is Bristol-Myers Squibb Stock a Millionaire Maker? ↗

December 02, 2024

Where Will Bristol Myers Squibb Be in 5 Years? ↗

November 24, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Dec. 16-20, 2024.

Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 21 ↗

December 21, 2024

Via Talk Markets

Topics Stocks / Equities

Want Decades of Passive Income? 3 Stocks to Buy Right Now ↗

December 21, 2024

Passive income requires solid companies and a solid underlying industry. Here are some top names that fit both bills.

Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services ↗

December 19, 2024

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.

Via Benzinga

3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring Income ↗

December 19, 2024

Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025

December 19, 2024

Got $250? 2 Healthcare Stocks to Buy and Hold Forever ↗

December 19, 2024

These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy? ↗

December 19, 2024

Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers

December 18, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:PFE),(NYSE:GSK),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers

December 18, 2024

From FN Media Group LLC

Via GlobeNewswire

Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy ↗

December 18, 2024

Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS.

Via Investor's Business Daily

Sanofi's 340B Credit Proposal Draws Federal Warning For Statutory Violation ↗

December 17, 2024

HRSA warns Sanofi that its credit model for 340B drugs violates the statute, demanding immediate cessation to avoid penalties and pricing agreement termination.

Via Benzinga

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields ↗

December 17, 2024

Via Benzinga

Bristol-Myers Squibb Shares Rise After Analyst Upgrades, Positive Pipeline Outlook ↗

December 16, 2024

Bristol-Myers Squibb Inc. (NYSE: BMY) shares saw are trading higher Monday. Jefferies analyst, Akash Tewari, raised his rating on the stock from Hold to Buy and increased the price target from $63 to...

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

December 16, 2024

Via Benzinga

Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday ↗

December 16, 2024

Via Benzinga

Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report ↗

December 13, 2024

ICER's 2023 report highlights five drugs with unsupported price increases, leading to $815 million in excess costs for U.S. payers. Discover key findings and trends.

Via Benzinga

Bristol Myers Squibb Announces Dividend Increase

December 11, 2024

Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline

December 09, 2024

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields ↗

December 03, 2024

Via Benzinga

Why Is Purple Biotech Stock Trading Higher On Monday? ↗

December 02, 2024

Purple Biotech's Phase 2 trial of CM24 in metastatic PDAC patients showed improved survival rates, biomarker responses, and disease control outcomes.

Via Benzinga

Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program ↗

November 29, 2024

Bristol Myers Squibb sues HRSA, claiming its rejection of a rebate model for 340B pricing violates federal law. The lawsuit highlights concerns over program abuse and regulatory overreach.

Via Benzinga

Topics Lawsuit

3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold Forever ↗

November 29, 2024

The sell-offs of these stocks were driven by issues that were never going to last.

Topics Stocks

Bristol Myers Squibb to Participate in Citi’s 2024 Global Healthcare Conference

November 26, 2024